Haemonetics Corporation (HAE)
Net profit margin
| Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 167,679 | 130,065 | 123,812 | 114,889 | 117,558 | 126,574 | 128,277 | 136,566 | 115,401 | 95,759 | 86,047 | 67,706 | 43,375 | 22,593 | 31,243 | 64,488 | 79,469 | 108,134 | 106,147 | 95,532 |
| Revenue (ttm) | US$ in thousands | 1,360,824 | 1,373,515 | 1,361,223 | 1,333,895 | 1,309,055 | 1,270,181 | 1,239,232 | 1,218,534 | 1,168,660 | 1,129,246 | 1,083,714 | 1,026,126 | 993,196 | 953,223 | 933,825 | 903,414 | 870,463 | 883,926 | 902,525 | 945,605 |
| Net profit margin | 12.32% | 9.47% | 9.10% | 8.61% | 8.98% | 9.97% | 10.35% | 11.21% | 9.87% | 8.48% | 7.94% | 6.60% | 4.37% | 2.37% | 3.35% | 7.14% | 9.13% | 12.23% | 11.76% | 10.10% |
March 31, 2025 calculation
Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $167,679K ÷ $1,360,824K
= 12.32%
Haemonetics Corporation's net profit margin has exhibited fluctuations over the past few years. The trend shows an increase from 10.10% as of June 30, 2020, reaching a peak of 12.32% by March 31, 2025. There were periods of decline, notably dropping to 2.37% on December 31, 2021, followed by a gradual recovery phase. The company experienced a significant improvement in profitability from the low of 2.37% to the high of 12.32% by focusing on cost management and revenue growth strategies. Overall, the net profit margin of Haemonetics Corporation demonstrates a mix of volatility and resilience, reflecting the company's ability to adapt to changing market conditions and internal challenges to enhance profitability.
Peer comparison
Mar 31, 2025